Please Wait
Applying Filters...
menu
    • menu
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Addyi

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Best Supplements Recalls WAP Capsules for Undeclared Active Drugs
    Best Supplements Recalls WAP Capsules for Undeclared Active Drugs

    18 May 2026

    // FDA

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/best-supplements-best-prices-issues-voluntary-nationwide-recall-wap-sensual-enhancement-capsules-due

    FDA
    18 May 2026
    Share Share
    Time Names Addyi Maker Sprout Pharma to 2026 Top 10
    Time Names Addyi Maker Sprout Pharma to 2026 Top 10

    29 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sprout-pharmaceuticals-makers-of-addyi-flibanserin-named-one-of-the-10-most-influential-health-and-life-science-companies-of-2026-by-time-302757517.html

    PR NEWSWIRE
    29 Apr 2026
    Share Share
    PHIL And Sprout Pharma Enhance Addyi Access Program
    PHIL And Sprout Pharma Enhance Addyi Access Program

    08 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/phil-and-sprout-pharmaceuticals-expand-their-affordable-direct-to-patient-access-program-for-addyiflibanserin-302655793.html

    PR NEWSWIRE
    08 Jan 2026
    Share Share
    FDA Approves Addyi For Postmenopausal Women's Sexual Health
    FDA Approves Addyi For Postmenopausal Women's Sexual Health

    15 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/historic-first-in-womens-sexual-health-fda-grants-approval-for-addyi-flibanserin-in-postmenopausal-women-302642397.html

    PR NEWSWIRE
    15 Dec 2025
    Share Share
    Addyi® Celebrates 10 Years Leading Women's Sexual Health
    Addyi® Celebrates 10 Years Leading Women's Sexual Health

    04 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/addyi-marks-a-decade-of-leadership-in-womens-sexual-health-302546088.html

    PR NEWSWIRE
    04 Sep 2025
    Share Share
    FDA Prioritizes Addyi® for Low Desire in Postmenopausal Women
    FDA Prioritizes Addyi® for Low Desire in Postmenopausal Women

    24 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/fda-grants-priority-review-for-addyi-flibanserin-paving-the-way-for-expanded-access-to-treat-low-sexual-desire-in-postmenopausal-women-302512883.html

    PR NEWSWIRE
    24 Jul 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.